RedHill Biopharma Ltd. (RDHL) income statement
RDHLNasdaqPharmaceutical Preparations
$0.28−0.04 (-13.08%)
Close on Nov 20, 2026Market cap $1.43MP/E –Yield –
RedHill Biopharma Ltd. financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $1.43MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||||||
| Gross margin | – | 60.3% | 47.0% | 46.1% | 42.4% | 42.7% | 64.1% | 66.1% | 46.9% | 100.0% | 100.0% | – |
| Operating margin | -2,776.9% | -80.5% | -146.2% | -69.3% | -94.6% | -99.0% | -686.7% | -470.5% | -1,297.0% | -30,240.6% | -733,400.0% | – |
| Free cash flow margin | -3,376.2% | -116.6% | -548.7% | -47.5% | -76.0% | -76.1% | -650.4% | -412.5% | -1,120.9% | -28,062.4% | -594,666.7% | – |
| Returns on capital | ||||||||||||
| Return on equity | 206.7% | 632.6% | -103.2% | 362.7% | -859.7% | -206.2% | -76.1% | -80.7% | -84.5% | -47.8% | -49.6% | – |
| Return on invested capital | – | – | – | -61.6% | -99.4% | -76.3% | – | – | – | – | – | – |
| Return on capital employed | -817.1% | 1,160.4% | 53.8% | -140.2% | -78.5% | -74.7% | -74.8% | -80.6% | -90.9% | -44.4% | – | – |
| Return on total capital | – | – | – | -53.8% | -86.4% | -66.9% | – | – | – | – | – | – |
| NOPAT | -$6.27M | -$5.12M | -$7.54M | -$33.85M | -$64.10M | -$50.31M | -$34.13M | -$31.07M | -$41.06M | -$24.13M | -$17.38M | – |
| Cash flow quality | ||||||||||||
| OCF / Sales | -3,374.5% | -116.5% | -548.5% | -47.2% | -75.9% | -75.5% | -647.7% | -412.2% | -1,117.3% | -27,978.2% | -594,200.0% | – |
| FCF / OCF | 100.1% | 100.1% | 100.0% | 100.7% | 100.2% | 100.8% | 100.4% | 100.1% | 100.3% | 100.3% | 100.1% | – |
| Unlevered free cash flow | -$8.51M | -$8.18M | -$28.52M | $4.10M | -$52.00M | -$38.91M | -$40.57M | -$34.35M | -$44.85M | -$28.05M | -$17.67M | – |
| Levered free cash flow | -$9.66M | -$9.38M | -$35.83M | -$29.38M | -$65.16M | -$48.99M | -$40.92M | -$34.49M | -$44.92M | -$28.34M | -$17.84M | – |
| Efficiency | ||||||||||||
| Asset turnover | 0.01 | 0.39 | 0.07 | 0.36 | 0.47 | 0.51 | 0.09 | 0.14 | 0.06 | 0.00 | – | – |
| Fixed asset turnover | 3.11 | 49.04 | 18.79 | 115.08 | 158.37 | 174.18 | 32.18 | 42.54 | 20.29 | 0.61 | – | – |
| Receivables turnover | 0.22 | 3.14 | 0.35 | 1.87 | 2.84 | 4.31 | 5.79 | 6.73 | 4.93 | 1.02 | – | – |
| Days sales outstanding | 1,670.6 | 116.4 | 1,037.2 | 195.5 | 128.4 | 84.7 | 63.1 | 54.3 | 74.1 | 357.8 | – | – |
| Payables turnover | – | 1.44 | 0.92 | 4.19 | 4.26 | 4.69 | 0.60 | 0.70 | 0.87 | – | – | – |
| Days payables outstanding | – | 254.2 | 396.1 | 87.0 | 85.8 | 77.8 | 606.6 | 522.9 | 417.6 | – | – | – |
| Inventory turnover | – | 0.79 | 0.45 | 2.58 | 4.63 | 8.78 | 1.70 | 3.99 | 3.26 | – | – | – |
| Days inventory outstanding | – | 459.7 | 812.4 | 141.3 | 78.8 | 41.6 | 214.2 | 91.5 | 112.1 | – | – | – |
| Operating cycle | – | 576.1 | 1,849.6 | 336.8 | 207.2 | 126.3 | 277.2 | 145.7 | 186.2 | – | – | – |
| Cash conversion cycle | – | 321.9 | 1,453.5 | 249.8 | 121.4 | 48.4 | -329.3 | -377.2 | -231.4 | – | – | – |
| CapEx to revenue | 1.7% | 0.11% | 0.17% | 0.32% | 0.13% | 0.63% | 2.7% | 0.28% | 3.6% | 84.2% | 466.7% | – |
| CapEx to OCF | -0.05% | -0.10% | -0.03% | -0.68% | -0.18% | -0.84% | -0.41% | -0.07% | -0.33% | -0.30% | -0.08% | – |
| Liquidity | ||||||||||||
| Current ratio | 0.34 | 0.54 | 0.81 | 0.44 | 1.09 | 0.96 | 5.01 | 5.47 | 4.37 | 12.66 | – | – |
| Quick ratio | 0.34 | 0.37 | 0.59 | 0.38 | 0.91 | 0.87 | 4.84 | 5.40 | 4.31 | 12.66 | – | – |
| Cash ratio | 0.21 | 0.21 | 0.28 | 0.10 | 0.36 | 0.40 | 2.73 | 2.79 | 1.39 | 10.04 | – | – |
| Working capital | -$12.69M | -$10.31M | -$3.84M | -$111.55M | $7.68M | -$2.74M | $42.60M | $46.41M | $39.85M | $62.46M | – | – |
| Net current asset value | -$14.55M | -$10.82M | -$4.84M | -$121.37M | -$83.16M | -$95.88M | $39.12M | $45.56M | $39.40M | $56.30M | – | – |
| Leverage | ||||||||||||
| Total debt | – | – | – | $115.22M | $83.62M | $81.39M | – | – | – | – | – | – |
| Net debt | – | – | – | $95.25M | $54.15M | $52.09M | – | – | – | – | – | – |
| Debt / Equity | – | – | – | -2.38 | 9.42 | 5.87 | – | – | – | – | – | – |
| Debt ratio | – | – | – | 72.5% | 46.2% | 45.2% | – | – | – | – | – | – |
| Assets to equity | 5.94 | -3.85 | 11.14 | -3.28 | 20.42 | 13.00 | 1.23 | 1.22 | 1.27 | 1.18 | – | – |
| Long-term debt to assets | – | – | – | – | 46.2% | 45.2% | – | – | – | – | – | – |
| Long-term debt to equity | – | – | – | – | 9.42 | 5.87 | – | – | – | – | – | – |
| Total debt / Capitalization | – | – | – | 172.4% | 90.4% | 85.4% | – | – | – | – | – | – |
| Long-term debt / Capitalization | – | – | – | – | 90.4% | 85.4% | – | – | – | – | – | – |
| Cash flow to debt | – | – | – | -25.3% | -77.8% | -59.7% | – | – | – | – | – | – |
| Intangibles to total assets | 20.9% | 30.7% | 24.2% | 41.3% | 39.5% | 48.8% | 22.8% | 8.5% | 9.2% | 8.2% | – | – |
| Interest coverage | ||||||||||||
| EBIT / Interest expense | -5.45 | -4.28 | -1.03 | -1.01 | -4.87 | -4.99 | -98.63 | -235.51 | -674.96 | -81.45 | -103.78 | – |
| Per share | ||||||||||||
| Revenue per share | 0.0000 | 0.0007 | 0.0025 | 0.10 | 0.18 | 0.18 | 0.02 | 0.04 | 0.02 | 0.0008 | 0.0000 | – |
| EPS (basic) | 0.00 | 0.00 | 0.01 | -0.12 | -0.21 | -0.21 | -0.14 | -0.17 | -0.26 | -0.23 | -0.19 | – |
| EPS (diluted) | 0.00 | 0.00 | 0.01 | -0.12 | -0.21 | -0.21 | -0.14 | 0.17 | -0.26 | -0.24 | -0.19 | – |
| Book value per share | 0.0001 | -0.0004 | 0.0008 | -0.08 | 0.02 | 0.04 | 0.20 | 0.22 | 0.26 | 0.49 | 0.54 | – |
| Tangible book value per share | -0.0000 | -0.0008 | -0.0014 | -0.19 | -0.13 | -0.20 | 0.15 | 0.20 | 0.23 | 0.44 | 0.54 | – |
| Cash per share | 0.0001 | 0.0004 | 0.0021 | 0.03 | 0.06 | 0.08 | 0.10 | 0.13 | 0.09 | 0.42 | 0.19 | – |
| Operating cash flow per share | -0.0003 | -0.0008 | -0.01 | -0.05 | -0.14 | -0.13 | -0.14 | -0.15 | -0.25 | -0.22 | -0.16 | – |
| Free cash flow per share | -0.0003 | -0.0008 | -0.01 | -0.05 | -0.14 | -0.13 | -0.14 | -0.15 | -0.25 | -0.22 | -0.16 | – |
| CapEx per share | 0.0000 | 0.0000 | 0.0000 | 0.0003 | 0.0002 | 0.0011 | 0.0006 | 0.0001 | 0.0008 | 0.0007 | 0.0001 | – |
| Valuation at period end | ||||||||||||
| Market cap | $1.27M | $1.61M | $2.25M | $6.53M | $93.98M | $239.91M | $140.34M | $98.00M | $66.21M | $116.85M | – | – |
| Enterprise value | -$1.60M | -$5.67M | -$4.75M | $65.05M | $125.33M | $296.83M | $131.35M | $92.44M | $12.42M | $95.34M | – | – |
| P/S | 4.4x | 0.2x | 0.3x | 0.1x | 1.1x | 3.7x | 22.3x | 11.7x | 16.5x | 1,157x | – | – |
| P/B | 0.3x | -0.3x | 1.1x | -0.1x | 10.6x | 17.3x | 2.3x | 1.9x | 1.5x | 1.9x | – | – |
| P/TBV | -1.2x | -0.2x | -0.6x | -0.1x | -1.5x | -3.2x | 3.3x | 2.1x | 1.7x | 2.1x | – | – |
| P/Gross profit | – | 0.3x | 0.7x | 0.2x | 2.6x | 8.7x | 34.8x | 17.7x | 35.2x | 1,157x | – | – |
| P/OCF | -0.1x | -0.2x | -0.1x | -0.2x | -1.4x | -4.9x | -3.4x | -2.8x | -1.5x | -4.1x | – | – |
| EV/Sales | -5.6x | -0.7x | -0.7x | 1.1x | 1.5x | 4.6x | 20.9x | 11.1x | 3.1x | 944x | – | – |
| EV/Gross profit | – | -1.2x | -1.5x | 2.3x | 3.4x | 10.8x | 32.6x | 16.7x | 6.6x | 944x | – | – |
| EV/EBIT | 0.2x | 0.9x | 0.5x | – | – | – | – | – | – | – | – | – |
| EV/OCF | 0.2x | 0.6x | 0.1x | -2.2x | -1.9x | -6.1x | -3.2x | -2.7x | -0.3x | -3.4x | – | – |
| EV/FCF | 0.2x | 0.6x | 0.1x | – | – | – | – | – | – | – | – | – |
| FCF yield | -760.8% | -582.8% | -1,592.8% | -450.1% | -69.3% | -20.4% | -29.2% | -35.2% | -67.8% | -24.3% | – | – |
| Cost structure | ||||||||||||
| R&D to revenue | 707.3% | 19.7% | 54.0% | 11.8% | 34.4% | 25.6% | 276.9% | 297.4% | 822.8% | 24,991.1% | 592,366.7% | – |
| SG&A to revenue | 2,158.0% | 60.8% | 92.2% | 46.3% | 37.7% | 39.4% | 182.5% | 89.8% | 200.3% | 3,809.9% | 91,600.0% | – |
| Stock-based comp to revenue | 159.8% | 8.3% | 25.2% | 9.2% | 11.9% | 6.5% | 48.1% | 32.0% | 55.8% | 1,662.4% | 45,466.7% | – |
| Per employee | ||||||||||||
| Total employees | 13 | 11 | 38 | 61 | 120 | 182 | 155 | 75 | 74 | 13 | 12 | 10 |
| Revenue per employee | $22.00K | $731.18K | $171.84K | $1.01M | $714.64K | $353.62K | $40.59K | $111.47K | $54.15K | $7.77K | $250 | – |
| Gross profit per employee | – | $441.00K | $80.82K | $466.61K | $302.93K | $150.92K | $26.01K | $73.64K | $25.42K | $7.77K | $250 | – |
| Operating profit per employee | -$610.92K | -$588.64K | -$251.26K | -$702.36K | -$676.13K | -$349.91K | -$278.72K | -$524.41K | -$702.32K | -$2.35M | -$1.83M | – |
| Free cash flow per employee | -$742.77K | -$852.55K | -$942.92K | -$481.69K | -$543.02K | -$269.15K | -$263.98K | -$459.80K | -$606.96K | -$2.18M | -$1.49M | – |
| Growth | ||||||||||||
| Revenue 1Y growth | -96.4% | 23.2% | -89.4% | -27.9% | 33.2% | 923.0% | -24.7% | 108.6% | 3,867.3% | 3,266.7% | – | – |
| Revenue 3Y CAGR | -83.3% | -54.6% | -53.4% | 114.2% | 117.3% | 152.3% | 296.4% | 1,307.2% | – | – | – | – |
| Revenue 5Y CAGR | -66.2% | 5.0% | -4.8% | 72.8% | 285.3% | 635.0% | – | – | – | – | – | – |
| Revenue 10Y CAGR | 57.7% | – | – | – | – | – | – | – | – | – | – | – |
| Gross profit 1Y growth | – | 58.0% | -89.2% | -21.7% | 32.3% | 581.2% | -27.0% | 193.6% | 1,762.4% | 3,266.7% | – | – |
| Gross profit 3Y CAGR | – | -48.9% | -51.8% | 91.8% | 87.4% | 144.4% | 241.8% | 1,125.6% | – | – | – | – |
| Gross profit 5Y CAGR | – | 3.8% | -11.1% | 72.2% | 224.5% | 519.9% | – | – | – | – | – | – |
| EBIT 1Y growth | -22.7% | 32.2% | 77.7% | 47.2% | -27.4% | -47.4% | -9.8% | 24.3% | -70.2% | -38.8% | – | – |
| Diluted EPS 1Y growth | – | -100.0% | 108.3% | 42.9% | 0.00% | -50.0% | -182.4% | 165.4% | -8.3% | -26.3% | – | – |
| Diluted EPS 5Y CAGR | – | – | -43.3% | – | – | – | – | – | – | – | – | – |
| Operating cash flow 1Y growth | -3.0% | 73.8% | -22.7% | 55.1% | -33.9% | -19.2% | -18.2% | 23.0% | -58.4% | -58.5% | – | – |
| Free cash flow 1Y growth | -3.0% | 73.8% | -21.9% | 54.9% | -33.0% | -19.7% | -18.7% | 23.2% | -58.5% | -58.9% | – | – |
| CapEx 1Y growth | -44.4% | -18.2% | -94.4% | 72.2% | -71.7% | 141.7% | 630.4% | -84.2% | 71.8% | 507.1% | – | – |
| CapEx 3Y CAGR | -70.7% | -57.2% | -70.0% | 5.6% | 71.0% | 40.6% | 25.5% | 18.0% | – | – | – | – |
| CapEx 5Y CAGR | -58.5% | -44.3% | -13.7% | 6.3% | 6.2% | 96.1% | – | – | – | – | – | – |
| CapEx 10Y CAGR | -9.8% | – | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | 40.5% | -21.7% | -85.5% | -12.3% | 0.53% | 143.2% | 18.7% | 8.8% | -22.7% | – | – | – |
| Total assets 3Y CAGR | -45.8% | -53.6% | -49.6% | 28.9% | 42.7% | 46.5% | -0.05% | – | – | – | – | – |
| Total assets 5Y CAGR | -32.5% | -24.6% | -18.1% | 22.6% | 19.5% | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.